River Wealth Advisors LLC Charles River Laboratories International, Inc. Transaction History

River Wealth Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $5,088 - $6,835	-25 Reduced 2.87%	847 $229,000
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $143,461 - $208,268	872 New	872 $206,000
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $202,496 - $299,980	-992 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $21,082 - $26,920	-60 Reduced 5.7%	992 $374,000
Q2 2021 Aug 06, 2021	BUY	$294.17 - $371.65 $5,883 - $7,433	20 Added 1.94%	1,052 $389,000
Q1 2021 May 11, 2021	BUY	$249.67 - $299.48 $34,953 - $41,927	140 Added 15.7%	1,032 $299,000
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $198,024 - $225,337	892 New	892 $223,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of River Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on River Wealth Advisors LLC with notifications on news.